Through this program, the ROI is making grants for high-risk, high-reward projects and/or seed funding necessary to demonstrate proof of concept before applying for larger grants. Projects can address any aspect of radiation oncology that falls within the scope of the priority research topic areas identified in the National Radiation Oncology Research Needs Assessment: quality and safety, comparative effectiveness, toxicity management, value and communication.
2016 Award Winners
Quality of Life and Biometric Parameter Predictors of Thoracic Radiotherapy Toxicity in Lung Cancer Patients
Geoffrey V. Martin, MD
University of Texas M.D. Anderson Cancer Center
In this clinical trial, Dr. Martin and his team are assessing the role of aggressive outpatient monitoring using smartphone-connected technology for lung cancer patients undergoing radiation therapy. The purpose of the study is to investigate the correlation between patient reported outcomes, continuous biometric monitoring (heart rate, pulse oximetry, lung function, etc.), and radiation-induced side effects.
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery
Nitin Ohri, MD
Albert Einstein College of Medicine
In this randomized trial, Dr. Ohri's team is investigating whether a simple, pedometer-based walking program can reduce treatment interruptions and thereby improve outcomes among cancer patients being treated with concurrent chemotherapy and radiation therapy. Participants will be given daily customized step count goals through fitness trackers provided by the study to determine if this relatively simple intervention can reduce the number of missed treatments, decrease treatment-related toxicities and improve quality of life for these cancer patients.